课题基金 / 基金详情

I-Corps: Device for Producing the Non-antibiotic Antimicrobial Hypothiocyanite (HTC) for Use in Food Safety

I-Corps: Device for Producing the Non-antibiotic Antimicrobial Hypothiocyanite (HTC) for Use in Food Safety
I-Corps:用于生产用于食品安全的非抗生素抗菌剂次硫氰酸盐 (HTC) 的装置
批准号:
1246308
负责人:
Michael Ashby
金额:
$5.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2013-12-31

项目摘要

项目成果

Michael Ashby的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project was considered using input from multiple directorates and program officers. It included verbal input from the I-Corps Cognizant Program Officers and written input from the Topic-Specific Directorate (included below). The intellectual merits as well as the broader impacts were considered and the team was invited to submit this proposal.Directorate Input:The PI has developed and patented a novel synthetic process to make the antimicrobial chemical, hypothiocyanate (HTC). HTC has the potential to be commercially used in the food safety market if it can be made cheaply. Currently meat producers in the US use hypochlorite to prevent ecoli contamination, but this molecule can produce carcinogens and, thus, has been banned in European markets. The PIs technology, produced under funding from a NSF grant from the Chemistry Division, should allow HTC to be made at a scale and price that would make it a safe alternative to hypochlorite.The team consists of the PI, Michael Ashby, who is a Professor of Chemistry at the University of Oklahoma. The Entrepreneurial Lead, Robert Free, is a graduate of the University of Oklahoma's (OU) Engineering Physics program. He is currently a Fellow in OU's Center for the Creation of Economic Wealth. Robert has experience in commercialization efforts. J. Boyd Nolan is the Entrepreneurial Mentor. He has experience at Boeing and has worked for several successful startups. It is my opinion that this team is excited about the opportunity to actively participate in the I-Corp Program and will benefit from it. For this reason and the fact that the discovery is in a commercially significant field, I recommend this proposal for I-Corp funding.Cognizant Program Director Recommendation:This I-Corps project builds upon previous work supported by NSF.The Previous Grants were:CHE-0503984CHE-0911328There is a clearly-defined market need and the team possesses the domain knowledge to justify I-Corps support. If successfully transitioned to a for-profit entity, there is potential for clear impact. The budget for $50,000 conforms to I-Corps requirements. The Academic team has discussed this effort with the I-Corps program directors and it is our unanimous recommendation to support this I-Corps project. This effort will be supported by MPS using the following codes:030000008023
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vulnerability of long-range axons in tauopathy
  • 批准号:
    MR/W005506/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $55.58万
  • 财政年份:
    2022
  • 负责人:
    Michael Ashby
  • 依托单位:
NRT-IGE: Advancing Graduate Education in the Chemical Sciences
  • 批准号:
    1633008
  • 项目类别:
    Standard Grant
  • 资助金额:
    $49.36万
  • 财政年份:
    2016
  • 负责人:
    Michael Ashby
  • 依托单位:
Template neuronal networks in developing neocortex
  • 批准号:
    MR/J013188/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $60.0万
  • 财政年份:
    2013
  • 负责人:
    Michael Ashby
  • 依托单位:
Chemical Mechanisms of Reactive Sulfur Species
  • 批准号:
    0911328
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $45.8万
  • 财政年份:
    2009
  • 负责人:
    Michael Ashby
  • 依托单位:
海外基金